Table 7 Serious adverse events possibly related to study treatment
Treatment group | Adverse event | Grade | Number of events |
|---|---|---|---|
Cilengitide and gemcitabine | Myocardial infarction | 4 | 1 |
Apoplexia | 4 | 1 | |
Thrombocytopenia | 3 | 1 | |
Exanthema | 1 | 1 | |
Weakness | 3 | 2 | |
Nausea | 3 | 1 | |
Anaphylactic reaction | 4 | 1 | |
Pulmonary embolism | 4 | 1 | |
Gastrointestinal hemorrhage | 3 | 1 | |
Hypotension1 | 3 | 1 | |
Erysipelas1 | 3 | 1 | |
Gemcitabine | Anorexia | 3 | 1 |
Exanthema | 2 | 1 | |
Depression | 3 | 1 | |
Dyspnea | 3 | 2 | |
Epistaxis | 2 | 1 | |
Pneumonia | 2 | 1 | |
Condition reduced1 | 3 | 1 |